The analysis of mRNA expression of bFGF in a reduced number of our B-CLL samples show the same referenced association, where T/- patients have lower bFGF expression levels than CC carrier patients (Supplementary Figure S1). The gene discussed is FGF2; the disease is B-cell chronic lymphocytic leukemia.